Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Upstream Processing01:27

Upstream Processing

97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
Recombinant DNA01:09

Recombinant DNA

92.4K
Overview
92.4K
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The evolving role of structural biology in pharma: integration of X-ray crystallography, cryo-electron microscopy and beyond.

Acta crystallographica. Section D, Structural biology·2026
Same author

Protein stability and viscosity in molecularly crowded high-concentration biologics.

Advanced drug delivery reviews·2026
Same author

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements.

The Journal of clinical investigation·2026
Same author

WRN structural flexibility showcased through fragment-based lead discovery of inhibitors.

Nature communications·2026
Same author

Structural Characterization of Linker Shielding in ADC Site-Specific Conjugates.

Pharmaceutics·2025
Same author

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

Science translational medicine·2024

Related Experiment Video

Updated: May 1, 2026

Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells: A Novel and Accessible Approach
11:20

Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells: A Novel and Accessible Approach

Published on: October 16, 2014

57.1K

Explanatory chapter: troubleshooting recombinant protein expression: general.

Krisna C Duong-Ly1, Sandra B Gabelli1

  • 1Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Methods in Enzymology
|March 29, 2014
PubMed
Summary
This summary is machine-generated.

Troubleshooting low recombinant protein expression is crucial for biochemists. This guide offers solutions for common issues, focusing on Escherichia coli (E. coli) expression systems to improve protein yields.

Keywords:
E. coli cell growthEukaryotic expression systemsMiniprep DNAT7 RNA polymeraseT7 expression vectorsXL1-Blue cells

More Related Videos

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

13.5K
A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
07:09

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells

Published on: July 31, 2012

20.8K

Related Experiment Videos

Last Updated: May 1, 2026

Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells: A Novel and Accessible Approach
11:20

Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells: A Novel and Accessible Approach

Published on: October 16, 2014

57.1K
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

13.5K
A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
07:09

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells

Published on: July 31, 2012

20.8K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biotechnology

Background:

  • Recombinant protein expression is vital for research and therapeutics.
  • Differences between host and source organisms often lead to expression challenges.
  • Escherichia coli (E. coli) is a widely used host for recombinant protein production.

Purpose of the Study:

  • To provide guidelines for identifying and diagnosing protein expression problems.
  • To elucidate common causes of low recombinant protein yields.
  • To present practical solutions for optimizing protein expression.

Main Methods:

  • Development of a protocol to measure protein expression during E. coli growth and post-induction.
  • Analysis of factors affecting protein expression in E. coli.
  • Review of various host cell expression systems with a focus on E. coli.

Main Results:

  • Identified key factors contributing to low protein expression.
  • Provided a framework for troubleshooting expression issues.
  • Demonstrated a method for monitoring expression levels.

Conclusions:

  • Low protein expression is a complex issue often requiring a combination of solutions.
  • The guidelines and methods presented are applicable to E. coli and potentially other expression systems.
  • Optimizing recombinant protein expression is achievable through systematic problem-solving.